|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/12/2010 12:38:04 PM
SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Corporation (“IntraOp”) (OTC: IOPD) announced today that it has retained NewCap Partners to act as financial and strategic advisor to assist the Board of Directors and management in evaluating strategic alternatives for the Company that may enhance shareholder value. The company has identified and developed several large markets for Interoperative Electron beam Radiation Therapy (”IOERT”) for the treatment of breast cancer and advanced tumors as well as External-beam Radiation Therapy (“EBRT”) for the treatment of skin cancer and believes that in order to maximize these markets, additional financial resources and infrastructure will be needed in the next year to meet these market opportunities in China, Europe and North America. John Powers, President and CEO of IntraOp, stated, "Interest by prospective customers and users continues to increase in the Mobetron, our mobile electron-beam radiation therapy system, from both the IOERT and EBRT markets. In addition, we have received expressions of strategic interest in IntraOp from other healthcare companies. Accordingly, we have decided to engage a financial advisor experienced in the healthcare sector to help us evaluate our financing and strategic alternatives, which could include an investment, a manufacturing or distribution alliance, a change of control transaction or other type of transaction.”
|
|
|
|
|
|
|
|
|
|
|